Literature DB >> 28109619

Obesity and Heart Failure: Focus on the Obesity Paradox.

Salvatore Carbone1, Carl J Lavie2, Ross Arena3.   

Abstract

The escalating prevalence of obesity has been linked to substantial increases in both metabolic and cardiovascular disease. Nevertheless, the direct effects of obesity on cardiovascular health and function require further exploration. In particular, the relationship between obesity and cardiac function has received intense scrutiny. Although obesity increases the risk for development of heart failure (HF), it appears to exert a protective effect in patients in whom HF has already been diagnosed (the "obesity paradox"). The protective effects of obesity in patients with previously diagnosed HF are the focus of particularly intense research. Several explanations have been proposed, but most studies are limited by the use of body mass index to classify obesity. Because body mass index does not distinguish between fat mass, fat-free mass, and lean mass, individuals with similar body mass indices may have vastly different body composition. This article discusses the roles of body composition, diet, cardiorespiratory fitness, and weight loss in the development of cardiac dysfunction and HF and the potential protective role that body composition compartments might play in improving HF prognosis. Based on an intensive literature search (Pubmed, Google Scholar) and critical review of the literature, we also discuss how a multidisciplinary approach including a nutritional intervention targeted to reduce systemic inflammation and lean mass-targeted exercise training could potentially exert beneficial effects for patients with HF.
Copyright © 2016 Mayo Foundation for Medical Education and Research. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2017        PMID: 28109619     DOI: 10.1016/j.mayocp.2016.11.001

Source DB:  PubMed          Journal:  Mayo Clin Proc        ISSN: 0025-6196            Impact factor:   7.616


  66 in total

Review 1.  Obesity: Pathophysiology and Management.

Authors:  Kishore M Gadde; Corby K Martin; Hans-Rudolf Berthoud; Steven B Heymsfield
Journal:  J Am Coll Cardiol       Date:  2018-01-02       Impact factor: 24.094

2.  Interleukin-1 blockade in heart failure with preserved ejection fraction: rationale and design of the Diastolic Heart Failure Anakinra Response Trial 2 (D-HART2).

Authors:  Benjamin W Van Tassell; Leo F Buckley; Salvatore Carbone; Cory R Trankle; Justin M Canada; Dave L Dixon; Nayef Abouzaki; Claudia Oddi-Erdle; Giuseppe Biondi-Zoccai; Ross Arena; Antonio Abbate
Journal:  Clin Cardiol       Date:  2017-05-05       Impact factor: 2.882

Review 3.  Cardiovascular effects of antiobesity drugs: are the new medicines all the same?

Authors:  Mauro Cataldi; Angelo Cignarelli; Francesco Giallauria; Giovanna Muscogiuri; Luigi Barrea; Silvia Savastano; Annamaria Colao
Journal:  Int J Obes Suppl       Date:  2020-07-20

4.  Sizing Up Fontan Failure: Association with Increasing Weight in Adulthood.

Authors:  Ryan D Byrne; Angela J Weingarten; Daniel E Clark; Steven J Healan; Tadarro L Richardson; Shi Huang; Jonathan N Menachem; Benjamin P Frischhertz
Journal:  Pediatr Cardiol       Date:  2021-05-04       Impact factor: 1.655

5.  Disproving the obesity paradox-not.

Authors:  Salvatore Carbone; Carl J Lavie
Journal:  Eur Heart J       Date:  2018-10-21       Impact factor: 29.983

Review 6.  Mechanisms linking adipose tissue inflammation to cardiac hypertrophy and fibrosis.

Authors:  Sarah R Anthony; Adrienne R Guarnieri; Anamarie Gozdiff; Robert N Helsley; Albert Phillip Owens; Michael Tranter
Journal:  Clin Sci (Lond)       Date:  2019-11-29       Impact factor: 6.124

7.  A Population-Based Study of Early Postoperative Outcomes in Patients with Heart Failure Undergoing Bariatric Surgery.

Authors:  Andrew T Strong; Gautam Sharma; Chao Tu; Ali Aminian; James B Young; John Rodriguez; Matthew Kroh
Journal:  Obes Surg       Date:  2018-08       Impact factor: 4.129

8.  Morbidity, mortality, and obesity paradox.

Authors:  Michael Spartalis; Eleni Tzatzaki; Demetrios Moris; Antonios Athanasiou; Eleftherios Spartalis
Journal:  Ann Transl Med       Date:  2017-11

9.  An Orally Available NLRP3 Inflammasome Inhibitor Prevents Western Diet-Induced Cardiac Dysfunction in Mice.

Authors:  Salvatore Carbone; Adolfo G Mauro; Andrea Prestamburgo; Matthew S Halquist; Pratyush Narayan; Nicola Potere; Eleonora Mezzaroma; Benjamin W Van Tassell; Antonio Abbate; Stefano Toldo
Journal:  J Cardiovasc Pharmacol       Date:  2018-12       Impact factor: 3.105

10.  Etiologies, predictors, and economic impact of readmission within 1 month among patients with takotsubo cardiomyopathy.

Authors:  Mahek Shah; Pradhum Ram; Kevin Bryan U Lo; Natee Sirinvaravong; Brijesh Patel; Byomesh Tripathi; Shantanu Patil; Vincent M Figueredo
Journal:  Clin Cardiol       Date:  2018-07-20       Impact factor: 2.882

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.